首页> 外文期刊>Nanotechnologies in Russia >Evaluation of the Uptake of PLGA-PEG Nanoparticles by Human Cancer Cells
【24h】

Evaluation of the Uptake of PLGA-PEG Nanoparticles by Human Cancer Cells

机译:用人癌细胞对PLGA-PEG纳米粒子摄取的评价

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the patterns of uptake of PLGA-PEG nanoparticles by human cancer cells, FITC-labeled polymer nanoparticles (FPN) are prepared and their properties are characterized. The amount of internalized FPN is measured by flow cytometry after quenching the fluorescence of the membrane-bound nanoparticles with Trypan Blue. The total uptake of the FPN by COLO 320 HSR and SW837 human cancer cells is shown to be proportional to the nanoparticle concentration and incubation time over a period of 24 h. The highest intracellular accumulation of the FPN is observed at 1 or 4 h, depending on the cell type. The translocation of the biodegradable and biocompatible polymer nanoparticles into the cancer cells that we observe may be the mechanism for enhancing the efficiency of the anticancer drug by loading it into these nanocarriers owing to a prolonged increase in the intracellular concentration of the therapeutic agent and the facilitation of its interaction with intracellular targets.
机译:为了研究通过人癌细胞吸收PLGA-PEG纳米颗粒的摄取模式,制备FITC标记的聚合物纳米颗粒(FPN),其性质表征。 通过流式细胞术在淬火膜结合纳米颗粒的荧光与台盼蓝后,通过流式细胞术测量内化FPN的量。 通过Colo 320 HSR和SW837人癌细胞的FPN的总摄取显示与纳米颗粒浓度和孵育时间在24小时内成比例。 根据细胞类型,在1或4小时内观察FPN的最高细胞内积聚。 将可生物降解和生物相容性聚合物纳米颗粒的易位转化为癌细胞,即我们观察到的癌细胞可能是由于延长治疗剂细胞内浓度和便利化的延长而通过将其加载到这些纳米骨架中来提高抗癌药物的效率 其与细胞内靶标的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号